OBJECTIVE: Bone marrow lesions are believed to increase risk of knee osteoarthritis (OA) progression. Whether their effect is local and whether it can be explained by other types of bone lesions concomitantly present in the same subregion is unclear. We evaluated bone lesion frequency in subregions without cartilage lesions and cartilage lesion frequency in subregions without bone lesions, and investigated the within-subregion bone marrow lesion/subsequent cartilage loss relationship after adjusting for other types of bone lesions at baseline. METHODS: Individuals with knee OA had magnetic resonance imaging at baseline and 2 years later. Cartilage integrity and bone marrow lesions, cysts, and attrition were scored within tibiofemoral subregions. Logistic regression, with generalized estimating equations to account for correlation among multiple subregions within a knee, was used to estimate odds ratios (ORs) for cartilage loss associated with bone marrow lesions, adjusting for age, sex, body mass index, and bone attrition and cysts in the same subregion. RESULTS: Analyzing 1,953 subregions among 177 knees, 90% of subregions had no bone lesions at baseline. Only 0-3% of subregions without cartilage lesions had bone lesions in the same subregion; in contrast, 5-33% of subregions without bone lesions had cartilage lesions. Bone marrow lesions at baseline were associated with cartilage loss in the same subregion at 2 years, adjusting for other types of bone lesions at baseline (adjusted OR 3.74, 95% confidence interval 1.59-8.82). CONCLUSION: In subjects with knee OA, bone marrow lesions were rare at early disease stages but predicted subregional cartilage loss after accounting for the presence of other types of bone lesions in the same subregion.
OBJECTIVE:Bone marrow lesions are believed to increase risk of knee osteoarthritis (OA) progression. Whether their effect is local and whether it can be explained by other types of bone lesions concomitantly present in the same subregion is unclear. We evaluated bone lesion frequency in subregions without cartilage lesions and cartilage lesion frequency in subregions without bone lesions, and investigated the within-subregion bone marrow lesion/subsequent cartilage loss relationship after adjusting for other types of bone lesions at baseline. METHODS: Individuals with knee OA had magnetic resonance imaging at baseline and 2 years later. Cartilage integrity and bone marrow lesions, cysts, and attrition were scored within tibiofemoral subregions. Logistic regression, with generalized estimating equations to account for correlation among multiple subregions within a knee, was used to estimate odds ratios (ORs) for cartilage loss associated with bone marrow lesions, adjusting for age, sex, body mass index, and bone attrition and cysts in the same subregion. RESULTS: Analyzing 1,953 subregions among 177 knees, 90% of subregions had no bone lesions at baseline. Only 0-3% of subregions without cartilage lesions had bone lesions in the same subregion; in contrast, 5-33% of subregions without bone lesions had cartilage lesions. Bone marrow lesions at baseline were associated with cartilage loss in the same subregion at 2 years, adjusting for other types of bone lesions at baseline (adjusted OR 3.74, 95% confidence interval 1.59-8.82). CONCLUSION: In subjects with knee OA, bone marrow lesions were rare at early disease stages but predicted subregional cartilage loss after accounting for the presence of other types of bone lesions in the same subregion.
Authors: David J Hunter; Yuqing Zhang; Jingbo Niu; Joyce Goggins; Shreyasee Amin; Michael P LaValley; Ali Guermazi; Harry Genant; Daniel Gale; David T Felson Journal: Arthritis Rheum Date: 2006-05
Authors: F W Roemer; A Guermazi; M K Javaid; J A Lynch; J Niu; Y Zhang; D T Felson; C E Lewis; J Torner; M C Nevitt Journal: Ann Rheum Dis Date: 2008-10-01 Impact factor: 19.103
Authors: C G Peterfy; A Guermazi; S Zaim; P F J Tirman; Y Miaux; D White; M Kothari; Y Lu; K Fye; S Zhao; H K Genant Journal: Osteoarthritis Cartilage Date: 2004-03 Impact factor: 6.576
Authors: David T Felson; Sara McLaughlin; Joyce Goggins; Michael P LaValley; M Elon Gale; Saara Totterman; Wei Li; Catherine Hill; Daniel Gale Journal: Ann Intern Med Date: 2003-09-02 Impact factor: 25.391
Authors: J-P Raynauld; J Martel-Pelletier; M-J Berthiaume; F Abram; D Choquette; B Haraoui; J F Beary; G A Cline; J M Meyer; J-P Pelletier Journal: Ann Rheum Dis Date: 2007-08-29 Impact factor: 19.103
Authors: G H Lo; A M Tassinari; J B Driban; L L Price; E Schneider; S Majumdar; T E McAlindon Journal: Osteoarthritis Cartilage Date: 2012-03-16 Impact factor: 6.576
Authors: M K Javaid; A Kiran; A Guermazi; C K Kwoh; S Zaim; L Carbone; T Harris; C E McCulloch; N K Arden; N E Lane; D Felson; M Nevitt Journal: Arthritis Rheum Date: 2012-10
Authors: Grace H Lo; Erika Schneider; Jeffrey B Driban; Lori Lyn Price; David J Hunter; Charles B Eaton; Marc C Hochberg; Rebecca D Jackson; C Kent Kwoh; Michael C Nevitt; John A Lynch; Timothy E McAlindon Journal: Semin Arthritis Rheum Date: 2018-01-31 Impact factor: 5.532
Authors: Hamza Alizai; Frank W Roemer; Daichi Hayashi; Michel D Crema; David T Felson; Ali Guermazi Journal: Eur Radiol Date: 2014-11-07 Impact factor: 5.315